tiprankstipranks
Trending News
More News >
Rallybio (RLYB)
NASDAQ:RLYB
US Market

Rallybio (RLYB) Financial Statements

Compare
357 Followers

Rallybio Financial Overview

Rallybio's market cap is currently $30.67M. The company's EPS TTM is $0.36; its P/E ratio is -2.21; Rallybio is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 636.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 636.00K$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -60.50M$ -78.93M$ -67.88M$ -45.65M$ -25.30M
EBITDA$ -60.37M$ -78.78M$ -67.72M$ -45.39M$ -25.24M
Net Income$ -57.77M$ -74.56M$ -66.65M$ -47.01M$ -26.45M
Balance Sheet
Cash & Short-Term Investments$ 65.51M$ 109.93M$ 168.99M$ 175.33M$ 140.23M
Total Assets$ 68.11M$ 115.62M$ 180.44M$ 182.19M$ 141.86M
Total Debt$ 154.00K$ 392.00K$ 555.00K$ 0.00$ 0.00
Net Debt$ -13.75M$ -24.10M$ -56.40M$ -175.33M$ -140.23M
Total Liabilities$ 6.45M$ 9.44M$ 11.12M$ 6.58M$ 5.86M
Stockholders' Equity$ 61.65M$ 106.18M$ 169.32M$ 175.60M$ 136.00M
Cash Flow
Free Cash Flow$ -49.28M$ -60.28M$ -57.34M$ -45.87M$ -22.18M
Operating Cash Flow$ -49.28M$ -60.27M$ -57.28M$ -45.53M$ -22.04M
Investing Cash Flow$ 33.49M$ 27.66M$ -112.17M$ -2.33M$ -2.07M
Financing Cash Flow$ 5.20M$ 143.00K$ 51.08M$ 82.97M$ 144.89M
Currency in USD

Rallybio Earnings and Revenue History

Rallybio Debt to Assets

Rallybio Cash Flow

Rallybio Forecast EPS vs Actual EPS